Profound Medical Corp. provided earnings guidance for full-year 2024. For the period, company expects total revenue to be in the range of $11.0 million to $12.0 million, which represents 53% to 67% growth compared to its prior year revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 CAD | +2.46% | -7.49% | -9.91% |
15/05 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
14/05 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.91% | 179M | |
+7.87% | 219B | |
+11.83% | 192B | |
+18.87% | 142B | |
+30.03% | 111B | |
+1.79% | 65.32B | |
+14.15% | 52.45B | |
+2.68% | 49.8B | |
+6.60% | 43.43B | |
+1.85% | 35.95B |
- Stock Market
- Equities
- PRN Stock
- News Profound Medical Corp.
- Profound Medical Corp. Provides Earnings Guidance for Full-Year 2024